Studied in patients with poor prognostic factors

A majority of patients had visceral metastases and >3 metastatic wp-content

  • Metastases1,2
  • Performance status1
  • Age1
  • Prior chemotherapy1,2
  • Prior anthracycline2
Metastatic Breast Cancer patient characteristics Metastatic Breast Cancer patient characteristics Metastatic Breast Cancer patient characteristics Metastatic Breast Cancer patient characteristics Metastatic Breast Cancer patient characteristics

Patients were well balanced across treatment arms

Studied in patients with poor prognostic factors

A majority of patients had visceral metastases and >3 metastatic wp-content

  • Metastases1,2
  • Performance status1
  • Age1
  • Prior chemotherapy1,2
  • Prior anthracycline2
Metastatic Breast Cancer patient characteristics Metastatic Breast Cancer patient characteristics Metastatic Breast Cancer patient characteristics Metastatic Breast Cancer patient characteristics Metastatic Breast Cancer patient characteristics

Patients were well balanced across treatment arms

INDICATION

ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

INDICATION

ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.